Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,662.7
-6.8 (-0.26%)

 

  • STI Straits Times Index
    2,662.7
    -6.8 (-0.26%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,584.4
    0.9 (0.06%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,248.9
    119.7 (0.46%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,427.2
    23.7 (0.70%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,478.4
    39.7 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,091.2
    15.1 (0.30%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 885.9M
  • Value: 292.3M
  • Rise: 123
  • Fall: 115
  • Unch: 570

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
QT Vascular0.009+0.004
AsiaMedic0.033+0.013
Singapore-eDev0.134+0.001
3Cnergy0.021+0.004
Medtecs Intl0.895+0.075
Thomson Medical0.061+0.002
Anchor Resources0.007+0.001
Clearbridge0.182+0.010
Healthway Med0.039+0.004
SingMedical0.270+0.015

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Yunnan Energy YUNNAN ENERGY INTL CO. LIMITED
Quotes 10 Minutes Delayed. Updated at 09 Jul 2020 08:56
Last (SGD): 0.159 Change: - High: - Remarks: -
Change (%): - Low: -
Open - Yesterday's Close 0.159
Buy Price 0.099 Sell Price -
Buy Volume ('000) 20.0 Sell Volume ('000) -
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.01244 Trailing EPS (SGD) e -0.01244 NAV (SGD) b 0.1764
PE a - Trailing PE f - Price / NAV b 0.9014
Dividend (SGD) d - Cash In Hand (SGD) g - Issued & Paid-up Shares c 275,437,000
Dividend Yield (%) d - Price / Cash In Hand g - Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 43.794
Beta - 500 Daysi -0.061 R-Squared - 500 Days (%)i 0.01 Enterprise Value (M) 42.102
Piotroski F Score 3 Exchange Code T43 Par Value ( USD ) 0.05000
52 Weeks Volatility (%) 54.96 6-Month VWAP n.a. Free Float (%) 49.0
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Wholesale and Retail Trade - Medical Specialties
Category Classification China
Index Components FTSE ST Fledgling Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 03 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Yunnan Energy SGX 43.794 - - 0.9014 -
Industry China SGX 630.975 14.472 21.883 0.7247 3.504
Medical Specialties SGX 3,143.350 160.841 90.204 14.6634 0.337
Index FTSE ST Fledgling Index SGX 81.532 21.346 21.232 0.6533 3.317
Local Peer Top Glove SGX 17,861.552 146.552 83.397 16.2779 0.353
Local Peer Medtecs Intl SGX 491.723 314.035 314.199 5.7409 -
Local Peer UG Healthcare SGX 386.303 154.147 189.923 9.0951 0.130
Local Peer Biolidics SGX 96.332 - - 8.8517 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 163,760.133 44.670 46.273 5.4193 1.421
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 152,699.905 41.315 41.619 5.3468 0.198
Global Peer DANAHER CORP NYSE 130,651.796 52.496 47.735 4.4356 0.362
Global Peer MEDTRONIC PLC NYSE 122,876.493 25.658 25.658 2.4218 2.357
Global Peer BECTON DICKINSON & CO NYSE 71,643.648 66.214 78.729 3.4199 1.170
Global Peer STRYKER CORP NYSE 68,132.486 32.709 31.485 5.1950 1.174
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,750.393 49.119 48.871 7.9644 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 49,362.622 10.503 11.514 3.5760 -
Global Peer BAXTER INTERNATIONAL INC NYSE 42,833.814 42.791 41.953 5.5636 1.004
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 42,960.931 32.891 32.891 3.0382 1.910
Other Global Peers EDWARDS LIFESCIENCES CORP (NYSE), DEXCOM INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), ALCON AG (NYSE), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), HARTA (Bursa), TOPGLOV (Bursa), STERIS PLC (NYSE), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), WATERS CORP (NYSE), WEIGAO GROUP (HKEx), PERKINELMER INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), QUIDEL CORP (NASDAQ), MICROPORT (HKEx), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), NOVOCURE LTD (NASDAQ), KANGJI MEDICAL (HKEx), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), GLOBUS MED INC (NYSE), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEVRO CORP (NYSE), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), AK MEDICAL (HKEx), INOVIO PHARMACEUTICALS INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), SUPERMX (Bursa), IRHYTHM TECHNOLOGIES INC (NASDAQ), PEIJIA-B (HKEx), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), LIVANOVA PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), EBOS GROUP (ASX), INARI MEDICAL INC (NASDAQ), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), CAREDX INC (NASDAQ), GLAUKOS CORPORATION (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), KDL MEDICAL (HKEx), SILK ROAD MEDICAL INC (NASDAQ), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), BIOTELEMETRY INC (NASDAQ), LIFETECH SCI (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), CIRC (HKEx), ZYNEX INC (NASDAQ), HESKA CORP (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), INOGEN INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), NATUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), SURMODICS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), AXOGEN INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), YESTAR HEALTH (HKEx), CYTOSORBENTS CORP (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), PW MEDTECH (HKEx), CORMEDIX INC (NYSE American), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), VIEWRAY INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), GOLDEN MEDITECH (HKEx), PROFOUND MED CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ALPHA PRO TECH (NYSE American), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), INVACARE CORP (NYSE), MISONIX INC (NASDAQ), CUTERA INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), DERMTECH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), VINCENT MED (HKEx), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), SOLITON INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), MODERN DENTAL (HKEx), SOLENO THERAPEUTICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), FONAR CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ROCKWELL MEDICAL INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), ELECTROMED INC (NYSE American), CELSION CORPORATION (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), CYCLOPHARM LIMITED (ASX), RESAPP HEALTH LIMITED (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), SOMNOMED LIMITED (ASX), NOVA EYE MEDICAL LIMITED (ASX), YUNNAN ENERGY (HKEx), MILESTONE SCIENTIFIC INC (NYSE American), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), LKL (Bursa), CONFORMIS INC (NASDAQ), SDI LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), COMPUMEDICS (ASX), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), DIMERIX LTD (ASX), RESONANCE HEALTH LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), KELFRED (HKEx), RESPIRI LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), IMMUCELL CORP (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ONCOCYTE CORP (NYSE American), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), NEURONETICS INC (NASDAQ), MICRO-X LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ELECTROCORE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), IRIDEX CORP (NASDAQ), OVENTUS MEDICAL LTD (ASX), LBT INNOVATIONS LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), NEUROTROPE INC (NASDAQ), METALICITY LIMITED (ASX), USCOM LTD (ASX), DARIOHEALTH CORP (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), CHF SOLUTIONS INC (NASDAQ), BIOLASE INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), LIFE HEALTHCARE (HKEx), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), AVINGER INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), AETHLON MEDICAL INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), DIGIRAD CORP (NASDAQ), OPTISCAN IMAGING (ASX), CYANOTECH CORP (NASDAQ), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), ADHERIUM LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ENDOLOGIX INC (NASDAQ), NEUROMETRIX INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), HUAKANG BIOMED (HKEx), STHAI (SET), ANALYTICA (ASX), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days ---
Medium Term Return 3 Months ---
6 Months ---
1 Year -+0.063
+65.62 %
Long Term Return 2 Years --0.526
-76.79 %
3 Years --0.191
-54.57 %
5 Years 0.005-0.191
-53.14 %
Annualised Return Annualised --
-14.07 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.092 - 0.160 Change From 1 Year Low +0.067 % Change From 1 Year Low (%) +72.83
Change From 1 Year High -0.001 % Change From 1 Year High (%) -0.62
2 Years Range 0.092 - 0.695 Change From 2 Years Low +0.067 % Change From 2 Years Low (%) +72.83
Change From 2 Years High -0.536 % Change From 2 Years High (%) -77.12
5 Years Range 0.092 - 0.695 Change From 5 Years Low +0.067 % Change From 5 Years Low (%) +72.83
Change From 5 Years High -0.536 % Change From 5 Years High (%) -77.12
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company was incorporated in Bermuda on 26 January 2004 under the name of Techcomp (Holdings) Limited. The Group is principally engaged in the design, development, manufacture and distribution of analytical instruments, life science equipment and laboratory instruments. It designs and manufactures various instruments, including gas and ion chromatographs, UV-Vis spectrophotometers and centrifuges for its house brand "Techcomp". The Group also manufactures for Hitachi High-Technologies Corporation on an original design manufacture ("ODM") basis. The Group’s manufacturing and distribution products address the academic, industrial, pharmaceutical, biotechnology and other research and laboratory markets, as well as the clinical laboratory and healthcare industries, agricultural and environmental industries, and government agencies. The Group’s products are used in industries and government agencies which conduct identification, quantification, material preparation and analysis of the elemental, molecular, physical, or biological composition or structure of liquids, solids, or gases. The Group has manufacturing operations in Shanghai and Tianjin. It has various technological partnerships and alliances, including agreements with Hitachi Naka Instrument Co Ltd for the development of UV-Vis spectrophotometers, Hitachi Koki Co Ltd for the development of centrifuges, and Alltech for the development of chromatographs.The Group distributes analytical instruments, life science equipment and laboratory instruments to customers in China, Hong Kong, Japan, Europe, the United States, Southeast Asia, South Asia and Australia through its trading subsidiaries located in Tianjin, Shanghai, Guangzhou, Hong Kong and Singapore, and its 11 liaison offices in China. Through its subsidiaries and third party distributors, it is also able to offer its customers maintenance and application support and repair services for all the products manufactured and distributed.

To more accurately reflect the Group’s current business activities and direction of future development, the company has changed its name from “Techcomp (Holdings) Limited” to “Yunnan Energy International Co. Limited”. Trading under new name with effect from 12 Dec 2018.

IPO Performance

Listing Date 12 Jul 2004 Full Subscription Rate (x) 5.42
No of Placement Shares (M) 37.00 No of Public Offer Shares (M) 3.00 Public Offer Subscription Rate (x) 59.90
IPO Price (SGD) a 0.267 First Day Close (SGD) a 0.290 First Week Close (SGD) a 0.253
Current vs IPO Price (%) -40.45 First Day Gain (%) +8.61 First Week Gain (%) -5.24
Notes:
  1. Adjusted for the following: Bonus Issue 1 for 2 on 04/05/2010

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(6.54 MB)
Part 2(6.60 MB)
Part 3(0.28 MB)
Part 4(0.50 MB)
Annual Report 2018 Dec 2018 Part 1(1.26 MB)
Part 2(1.42 MB)
Part 3(0.29 MB)
Part 4(0.51 MB)
Annual Report 2017 Dec 2017 Part 1(5.92 MB)
Part 2(6.03 MB)
Part 3(0.10 MB)
Part 4(0.20 MB)
Annual Report 2016 Dec 2016 Part 1(4.85 MB)
Part 2(0.10 MB)
Part 3(4.15 MB)
Part 4(0.21 MB)
Annual Report 2015 Dec 2015 Part 1(2.46 MB)
Part 2(0.10 MB)
Part 3(2.98 MB)
Part 4(0.20 MB)
Annual Report 2014 Dec 2014 Part 1(1.72 MB)
Annual Report 2013 Dec 2013 Part 1(4.97 MB)
Part 2(0.05 MB)
Part 3(0.13 MB)
Annual Report 2012 Dec 2012 Part 1(1.04 MB)
Annual Report 2011 Dec 2011 Part 1(1.21 MB)
Annual Report 2010 Dec 2010 Part 1(0.91 MB)
Annual Report 2009 Dec 2009 Part 1(3.10 MB)
Annual Report 2008 Dec 2008 Part 1(1.76 MB)
Annual Report 2007 Dec 2007 Part 1(1.33 MB)
Annual Report 2006 Dec 2006 Part 1(1.05 MB)
Annual Report 2005 Dec 2005 Part 1(1.25 MB)
Interim Report
Interim Report 2019 Jun 2019 Part 1(0.77 MB)
Part 2(1.41 MB)
Interim Report 2018 Jun 2018 Part 1(1.65 MB)
Part 2(1.08 MB)
Interim Report 2017 Jun 2017 Part 1(0.88 MB)
Part 2(1.38 MB)
Interim Report 2016 Jun 2016 Part 1(0.18 MB)
Part 2(0.62 MB)
Interim Report 2015 Jun 2015 Part 1(0.49 MB)
Part 2(1.44 MB)
Interim Report 2014 Jun 2014 Part 1(0.22 MB)
Part 2(0.72 MB)
Interim Report 2013 Jun 2013 Part 1(1.02 MB)
Interim Report 2012 Jun 2012 Part 1(0.16 MB)
IPO Prospectus
IPO Prospectus 2004 Jul 2004 Part 1(2.46 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
08 Jul 2020 0.159 0.159 0.159 0.159 - -
07 Jul 2020 0.159 0.159 0.159 0.159 - -
06 Jul 2020 0.159 0.159 0.159 0.159 - -
03 Jul 2020 0.159 0.159 0.159 0.159 - -
02 Jul 2020 0.159 0.159 0.159 0.159 - -
01 Jul 2020 0.159 0.159 0.159 0.159 - -
30 Jun 2020 0.159 0.159 0.159 0.159 - -
29 Jun 2020 0.159 0.159 0.159 0.159 - -
26 Jun 2020 0.159 0.159 0.159 0.159 - -
25 Jun 2020 0.159 0.159 0.159 0.159 - -
24 Jun 2020 0.159 0.159 0.159 0.159 - -
23 Jun 2020 0.159 0.159 0.159 0.159 - -
22 Jun 2020 0.159 0.159 0.159 0.159 - -
19 Jun 2020 0.159 0.159 0.159 0.159 - -
18 Jun 2020 0.159 0.159 0.159 0.159 - -
17 Jun 2020 0.159 0.159 0.159 0.159 - -
16 Jun 2020 0.159 0.159 0.159 0.159 - -
15 Jun 2020 0.159 0.159 0.159 0.159 - -
12 Jun 2020 0.159 0.159 0.159 0.159 - -
11 Jun 2020 0.159 0.159 0.159 0.159 - -
10 Jun 2020 0.159 0.159 0.159 0.159 - -
09 Jun 2020 0.159 0.159 0.159 0.159 - -
Summary
Current 2 Weeks
(25 Jun 2020 to 08 Jul 2020)
0.159 0.159 0.159 0.159 - -
Previous 2 Weeks
(11 Jun 2020 to 24 Jun 2020)
0.159 0.159 0.159 0.159 - -
4 Weeks from
(13 May 2020 to 10 Jun 2020)
0.159 0.159 0.159 0.159 - -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.